Triantafyllos K. Doskas
Alexandroupoli, ESYE11 68100, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Explainable Machine Learning in the Prediction of Depression.
Journal: Diagnostics (Basel, Switzerland)
Published: April 29, 2025
Neurocognitive Impairment After COVID-19: Mechanisms, Phenotypes, and Links to Alzheimer's Disease.
Journal: Brain sciences
Published: April 24, 2025
Beyond Physical Disability: The Social Cognition Challenges in Quality of Life Among Multiple Sclerosis Patients.
Journal: Healthcare (Basel, Switzerland)
Published: April 22, 2025
Clinical insights and risk factors for disability in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorder patients: a multicenter real-world study in Greece.
Journal: Multiple sclerosis and related disorders
Published: April 05, 2025
Clinical Efficacy of a Combined Cognitive-Language Rehabilitation Intervention: Evidence From Greek Patients With Stroke-Induced Aphasia.
Journal: Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists
Published: December 10, 2024
The mediating role of processing speed on the relationship between executive functions and social cognition in relapsing-remitting multiple sclerosis patients.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: August 03, 2024
SARS-CoV-2-Induced Type I Interferon Signaling Dysregulation in Olfactory Networks Implications for Alzheimer's Disease.
Journal: Current issues in molecular biology
Published: January 10, 2024
Neurocognitive Impairment and Social Cognition in Parkinson's Disease Patients.
Journal: Neurology international
Published: January 03, 2024
Social Cognition Impairments in Association to Clinical, Cognitive, Mood, and Fatigue Features in Multiple Sclerosis: A Study Protocol.
Journal: Neurology international
Published: July 14, 2023
Correction: Masitinib for mild-to-moderate Alzheimer's disease: results from a randomized, placebo-controlled, phase 3, clinical trial.
Journal: Alzheimer's research & therapy
Published: April 22, 2023
Leukoaraiosis as a Predictor of Depression and Cognitive Impairment among Stroke Survivors: A Systematic Review.
Journal: Neurology international
Published: December 29, 2022
Last Updated: 09/26/2026